FDA Law Blog

DECEMBER 6, 2024

By Mark A. Tobolowsky & Charles G. Raver & James E. Valentine On November 19, 2024, FDA released a draft guidance titled Frequently Asked Questions Developing Potential Cellular and Gene Therapy Products. As much of the content of this draft guidance for cellular and gene therapy (CGT) products is articulated elsewhere, this document serves as a one-stop shop or Cliffs Notes for the numerous guidance documents now covering CGT product development.

Gene Therapy 57

Gene Therapy Gene Production In-Vivo 57

Pharmaceutical Technology

DECEMBER 6, 2024

Eli has announced a $3bn investment to expand its newly acquired manufacturing facility in Kenosha County, Wisconsin, in the US.

Manufacturing 173

Manufacturing 173

Bio Pharma Dive

DECEMBER 6, 2024

195

195

Pharmaceutical Technology

DECEMBER 6, 2024

The new FDA guidance outlines how surrogate or intermediate clinical endpoints can support accelerated approval.

162

162

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Bio Pharma Dive

DECEMBER 6, 2024

Production 120

Production Drugs 120

Pharmaceutical Technology

DECEMBER 6, 2024

A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.

147

147

Pharmaceutical Technology

DECEMBER 6, 2024

Investment for companies developing cell and gene therapies (CGTs) was discussed during the GenScript Biotech Global Forum London 2024 conference held on 20 November 2024.

Gene Therapy 147

Gene Therapy Gene Development 147

Medical Xpress

DECEMBER 6, 2024

Brainmachine interfaces (BMIs) have enabled a handful of test participants who are unable to move or speak to communicate simply by thinking. An implanted device picks up the neural signals associated with a particular thought and converts them into control signals that are fed into a computer or a robotic limb. For example, a quadriplegic person is asked to think about moving a cursor on a computer screen.

90

90

Pharmaceutical Technology

DECEMBER 6, 2024

Centenarians present a unique opportunity for researchers to explore longevity, they demonstrate impressive resilience to illness and injury.

Research 147

Research 147

Medical Xpress

DECEMBER 6, 2024

There is a U-shaped association between alcohol consumption and coronary heart disease (CHD) and type 2 diabetes (T2D) but no evidence for a causal association, according to a study published online Nov. 24 in Alcohol: Clinical and Experimental Research.

Research 87

Research Cardiology 87

Advertisement

Clinical Supply

Pharmaceutical Technology

DECEMBER 6, 2024

The US FDA has granted RMAT designation to Affimed and Artiva Biotherapeutics combination therapy for lymphoma.

147

147

XTalks

DECEMBER 6, 2024

In a highly anticipated head-to-head trial of Eli Lillys Zepbound (tirzepatide) and Novo Nordisks Wegovy (semaglutide), Zepbound has come out on top as it helped trial participants lose significantly more weight than Wegovy over an 18-month period. Patients treated with Zepbound achieved an average weight loss of 20.2 percent of their body weight, compared to 13.7 percent for those on Wegovy.

Trials 78

Trials Clinical Trials Clinical Trials Marketing 78

Pharmaceutical Technology

DECEMBER 6, 2024

Muna has entered a research alliance with GSK to expedite Alzheimer's disease treatments by discovering and validating new drug targets.

Drugs 147

Drugs Research 147

XTalks

DECEMBER 6, 2024

Kinevant Sciences, a unit in Roivant, announced that its Phase II RESOLVE-Lung study of namilumab, an investigational treatment for chronic active pulmonary sarcoidosis, did not meet its primary or secondary endpoints. Consequently, the company has decided to discontinue the development of the drug for this condition. This setback comes amid progress in Roivants broader clinical pipeline.

Trials 80

Trials Drugs Antibody Clinical Trials 80

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Technology

DECEMBER 6, 2024

A study published in Nature estimates the economic burden associated with obesity on major US industries to be in excess of $347bn in 2023.

130

130

Medical Xpress

DECEMBER 6, 2024

The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due to the high genetic diversity of the virus. A research team has now achieved promising results. Using epitope-focused immunogens, they were able to induce broadly neutralizing antibodies (bnAbs) in laboratory models for the first time.

Vaccination 81

Vaccination Vaccine Genetics Antibody 81

pharmaphorum

DECEMBER 6, 2024

81

81

Fierce Pharma

DECEMBER 6, 2024

81

81

Advertisement

Clinical Supply

pharmaphorum

DECEMBER 6, 2024

Manufacturing 81

Manufacturing 81

Medical Xpress

DECEMBER 6, 2024

A breakthrough by researchers at Peter Mac will allow scientists to detect, analyze and profile cancer tumors in patients via a simple blood test. The Dawson lab at Peter Mac has developed a method that can take circulating tumor DNA (ctDNA) from the patient's blood and use an algorithm to identify cancer-related changes and patterns in their DNA.

DNA 77

DNA Scientist Development Research 77

pharmaphorum

DECEMBER 6, 2024

Insulin 79

Insulin 79

Fierce Pharma

DECEMBER 6, 2024

76

76

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

Medical Xpress

DECEMBER 6, 2024

Experts have used magnetic resonance imaging (MRI) to better understand the impact a gluten free diet has on people with celiac disease, which could be the first step towards finding new ways of treating the condition.

Radiology 75

Radiology 75

pharmaphorum

DECEMBER 6, 2024

75

75

Medical Xpress

DECEMBER 6, 2024

Cleveland Clinic Genome Center researchers have unraveled how immune cells called microglia can transform and drive harmful processes like neuroinflammation in Alzheimer's disease. The study, published in the journal Alzheimer's & Dementia, also integrates drug databases with real-world patient data to identify FDA-approved drugs that may be repurposed to target disease-associated microglia in Alzheimer's disease without affecting the healthy type.

FDA Approval 74

FDA Approval Genomics Genome Drugs 74

pharmaphorum

DECEMBER 6, 2024

75

75

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

Medical Xpress

DECEMBER 6, 2024

A significant advance in breast cancer research has uncovered a key mechanism driving cancer invasion and drug resistance. A University of Liverpool study reveals how two critical molecules present in "HER2-positive" breast cancerone of the most aggressive formsinfluence breast cancer survival and its spread. The findings are published in the journal Science Advances.

Research 73

Research Drugs 73

pharmaphorum

DECEMBER 6, 2024

74

74

Medical Xpress

DECEMBER 6, 2024

Exactly why do people remember what they remember? A recently published review paper from researchers at Rice University sheds light on this fundamental question and the relationship between factors that influence human memory.

Research 73

Research 73

Fierce Pharma

DECEMBER 6, 2024

Drugs 67

Drugs 67

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials